GHN Pharma AB

Active
556562-3716Limited company (AB)Registered 1998MÖLNDAL

Key figures

81 255 kr−90,3%
Revenue 2020
−90,3%
Average annual change 2019–2020
0250 k500 k750 k1 m20192020

Key figures

2020

Summary: GHN Pharma AB

What kind of company is it?

GHN Pharma AB (org. no. 556562-3716) is a limited company (AB). The company was registered in 1998 and has existed for 27 years. Registered seat: Mölndal. Industry according to Statistics Sweden: activities of business membership organisations (SNI 94111).

How is the company doing financially?

Net sales in financial year 2020 were 81 255 kr, down 90,3 % on the previous year (840 496 kr). Net profit for 2020 was 3 078 524 kr (3 789 % of net sales). Employees in financial year 2020: 2 (previous year: 1). Net sales per employee were 40 628 kr. At the end of financial year 2020, total assets were 79 869 794 kr and equity 79 351 267 kr (equity ratio 99,4 %). The annual report for 2020 proposes a dividend of 520 000 kr.

What should you look out for?

The latest digitally filed annual report is for 2020.

Where does the data come from and how up to date is it?

Company details and digitally filed annual reports come from the open data of the Swedish Companies Registration Office (Bolagsverket) and the industry code from Statistics Sweden (CC BY 2.5 SE); bolagsprofil.se updates them daily. The latest annual report is signed by 2 people. Data as of 2026-11-16. Changes, averages and ratios are calculated by bolagsprofil.se from open data and are not an official assessment.

Dividend

from the annual report
2020

Proposed dividend 520 000 kr.

Summary of annual reports2019–2020
20192020
Sales revenue840 49681 255
Profit for the reporting year9 794 5083 078 524
Retained earnings of previous periods——
Total assets77 503 80979 869 794
Total liabilities1 051 066518 527
Total equity76 452 74379 351 267
Employees12
Proposed dividend—520 000

A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.